

The U.S. and European countries are securing thousands of additional treatments and vaccines to prevent the worst case. While cases

Josh Hardy, the little boy fighting for his life as an adenovirus infection ravages his body, has just been enrolled

Chimerix, a drug company that manufactures the still-developmental drug Brincidofovir, is denying the potentially lifesaving drug to 7-year-old Josh Hardy.